1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Intermittent Fasting: new trials by email Literature Review of Intermittent Fasting trials Research Report on Intermittent Fasting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy Atezolizumab, Avelumab, Cemiplimab - Advanced Malignant Skin Neoplasm, Metastatic Malignant Skin Neoplasm | Phase 1 | Active not recruiting | University of Southern California | 10 | 2020-08-12 | 2026-09-21 |
Skin Neoplasms (1)
University of Southern California (1)
United States (1)
Gino K In, MD (1)
P30CA014089 (1)